Adrianna Murphy|Benjamin Palafox|Owen O’Donnell|David Stuckler|Pablo Perel|Khalid F. AlHabib|Álvaro Avezum|Xia Bai|Jephat Chifamba|Clara K Chow|Daniel J. Corsi|Gilles R. Dagenais|Antonio L. Dans|Rafael D??az|Ay?e Naciye Erbakan|Noorhassim Ismail|Romaina Iqbal|Roya Kelishadi|Rasha Khatib|Fernando Lanas|Scott A. Lear|Wei Li|Jia Liu|Patricio López?Jaramillo|Viswanathan Mohan|Nahed Monsef|Prem Mony|Thandi Puoane|Sumathy Rangarajan|Annika Rosengren|Aletta E. Schutte|Mariz Sintaha|Koon Teo|Andreas Wielgosz|Karen Yeates|Lu Yin|Khalid Yusoff|Katarzyna Zato?ska|Salim Yusuf|Martin McKee
Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study
London School of Hygiene & Tropical Medicine|London School of Hygiene & Tropical Medicine|Erasmus University Rotterdam|University of Lausanne|Bocconi University|London School of Hygiene & Tropical Medicine|King Saud University|Universidade de Santo Amaro|Chinese Academy of Medical Sciences & Peking Union Medical College|University of Zimbabwe|The George Institute for Global Health|University of Sydney|Ottawa Hospital|Institut Universitaire de Cardiologie et de Pneumologie de Québec|University of the Philippines Manila|Estudios Clínicos Latinoamérica|University Kebangsaan Malaysia Medical Centre|Aga Khan University|Isfahan University of Medical Sciences|Loyola University Medical Center|Universidad de La Frontera|Simon Fraser University|Chinese Academy of Medical Sciences & Peking Union Medical College|Chinese Academy of Medical Sciences & Peking Union Medical College|Foscal Hospital|Madras Diabetes Research Foundation|Dr. Mohan's Diabetes Specialities Centre|Dubai Health Authority|St.John's Medical College Hospital|University of the Western Cape|Population Health Research Institute|Hamilton General Hospital|McMaster University|Sahlgrenska University Hospital|University of Gothenburg|South African Medical Research Council|North-West University|Independent University|Population Health Research Institute|Hamilton General Hospital|McMaster University|University of Ottawa|Queen's University|Chinese Academy of Medical Sciences & Peking Union Medical College|Universiti Teknologi MARA|UCSI University|Wroclaw Medical University|Population Health Research Institute|Hamilton General Hospital|McMaster University|London School of Hygiene & Tropical Medicine
little evidence use secondary prevention medicines cardiovascular disease socioeconomic groups countries different levels economic developmentwe assessed use antiplatelet cholesterol bloodpressurelowering drugs 8492 individuals selfreported cardiovascular disease 21 countries enrolled prospective urban rural epidemiology pure study defining one drugs minimal level secondary prevention wealthrelated inequality measured using wagstaff concentration index scaled 1 propoor 1 prorich standardised age sex correlations inequalities national healthrelated indicators estimatedthe proportion patients cardiovascular disease three medications ranged 0 south africa 95 ci 017 tanzania 036 zimbabwe 051 493 canada 444543 proportions receiving least one drug varied 20 95 ci 0569 tanzania 914 866946 sweden significant p005 prorich inequality saudi arabia china colombia india pakistan zimbabwe propoor distributions observed sweden brazil chile poland occupied palestinian territory strongest predictors inequality public expenditure health overall use secondary prevention medicinesuse medication secondary prevention cardiovascular disease alarmingly low many countries lowest use prorich inequality greatest policies associated equal propoor distribution include free medications community health programmes support adherence medicationsfull funding sources listed end paper see acknowledgments